Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2019 | 1 |
2021 | 3 |
2023 | 1 |
2024 | 0 |
PubMed (GeneRIF) for id: 79037
7 results
Results by year
Filters applied: . Clear all
Page 1
Nonredundant Upregulation of CD112R (PVRIG) and PD-1 on Cytotoxic T Lymphocytes Located in T Cell Nests of Colorectal Cancer.
Mod Pathol. 2023 Apr;36(4):100089. doi: 10.1016/j.modpat.2022.100089. Epub 2023 Jan 10.
Mod Pathol. 2023.
PMID: 36788088
Free article.
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade.
Hansen K, Kumar S, Logronio K, Whelan S, Qurashi S, Cheng HY, Drake A, Tang M, Wall P, Bernados D, Leung L, Ophir E, Alteber Z, Cojocaru G, Galperin M, Frenkel M, White M, Hunter J, Liang SC, Kotturi MF.
Hansen K, et al.
Cancer Immunol Immunother. 2021 Dec;70(12):3525-3540. doi: 10.1007/s00262-021-02921-8. Epub 2021 Apr 26.
Cancer Immunol Immunother. 2021.
PMID: 33903974
Free PMC article.
Item in Clipboard
Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy.
Jin HS, Park Y.
Jin HS, et al.
BMB Rep. 2021 Jan;54(1):2-11. doi: 10.5483/BMBRep.2021.54.1.229.
BMB Rep. 2021.
PMID: 33298247
Free PMC article.
Review.
Item in Clipboard
PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia.
Li J, Whelan S, Kotturi MF, Meyran D, D'Souza C, Hansen K, Liang S, Hunter J, Trapani JA, Neeson PJ.
Li J, et al.
Haematologica. 2021 Dec 1;106(12):3115-3124. doi: 10.3324/haematol.2020.258574.
Haematologica. 2021.
PMID: 33147937
Free PMC article.
Item in Clipboard
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function.
Whelan S, Ophir E, Kotturi MF, Levy O, Ganguly S, Leung L, Vaknin I, Kumar S, Dassa L, Hansen K, Bernados D, Murter B, Soni A, Taube JM, Fader AN, Wang TL, Shih IM, White M, Pardoll DM, Liang SC.
Whelan S, et al.
Cancer Immunol Res. 2019 Feb;7(2):257-268. doi: 10.1158/2326-6066.CIR-18-0442. Epub 2019 Jan 18.
Cancer Immunol Res. 2019.
PMID: 30659054
Free PMC article.
Item in Clipboard
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.
Xu F, Sunderland A, Zhou Y, Schulick RD, Edil BH, Zhu Y.
Xu F, et al.
Cancer Immunol Immunother. 2017 Oct;66(10):1367-1375. doi: 10.1007/s00262-017-2031-x. Epub 2017 Jun 16.
Cancer Immunol Immunother. 2017.
PMID: 28623459
Free PMC article.
Item in Clipboard
Identification of CD112R as a novel checkpoint for human T cells.
Zhu Y, Paniccia A, Schulick AC, Chen W, Koenig MR, Byers JT, Yao S, Bevers S, Edil BH.
Zhu Y, et al.
J Exp Med. 2016 Feb 8;213(2):167-76. doi: 10.1084/jem.20150785. Epub 2016 Jan 11.
J Exp Med. 2016.
PMID: 26755705
Free PMC article.
Item in Clipboard
Cite
Cite